BioSpace News Archive

Vaccitech plc announced an update to the interim analysis of safety and efficacy data from the HBV002 study, which is being presented as a poster at the 2022 EASL International Liver CongressTM by Professor Ellie Barnes, Professor of Hepatology and Experimental Medicine at the University of Oxford.

Patients’ expectations of healthcare technology are changing to reflect the digital conveniences they are used to in other aspects of their lives, according to research in a newly published white paper from Phreesia.

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Affilogic today announced that the companies have expanded their research and development (R&D) collaboration, which was initially formed in 2018, to include the development of Nanofitins® targeting the transferrin receptor (TfR), which enables drugs to be transported across the blood brain barrier and into the central nervous system.

Krystal Biotech, Inc. announced the submission of a Biologics License Application to the U.S. Food and Drug Administration seeking approval of B-VEC for the treatment of patients with dystrophic epidermolysis bullosa.

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the election of Kenneth M. Ferguson, Ph.D., to its Board of Directors.

POXEL SA, a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis and rare metabolic disorders, announces that it held its ordinary annual and extraordinary general meeting of shareholders on June 21, 2022.

Wilmington, Delaware, United States: Transparency Market Research has published a new report titled, “Contrast Media Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Wilmington, Delaware, United States: Mesotherapy is a technique that is used to inject vitamins, enzymes, hormones, and plant extracts to rejuvenate and tighten skin as well as remove excess fat.

Wilmington, Delaware, United States: The advancements in the healthcare industry and the proponents of healthcare systems are likely to amplify their reliance on the cold chain logistics for healthcare.

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of a research test, codeveloped with Merck.